4.8 Article

PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells

Journal

CANCER RESEARCH
Volume 64, Issue 19, Pages 6906-6914

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-04-1767

Keywords

-

Categories

Funding

  1. NCI NIH HHS [R01 CA115699, K01 CA87828, R01 CA115699-01A1, R01 CA115699-02, R01 CA115699-03, P30 CA051008, P30 CA51008, K01 CA087828, T32 CA009686, R01 CA115699-04, R01 CA115699-05, R01 CA115699-03S1] Funding Source: Medline

Ask authors/readers for more resources

Following DNA damage, human cells arrest primarily in the G(1) and G(2) phases of the cell cycle. Here, we show that after irradiation, human cancer cells with targeted deletion of PTEN or naturally occurring PTEN mutations can exert G(1) and G(2) arrests but are unable to arrest in size. Pharmacological inhibition of phosphoinositol-3-kinase, or mTOR in PTEN-/- cells restored the size arrest, whereas siRNA-mediated depletion of TSC2 in PTEN+/+ cells attenuated the size arrest. Radiation treatment potentiated Akt activation in PTEN-/- but not PTEN+/+ cells. Finally, abrogation of the size arrest via PTEN deletion conferred radiosensitivity both in vitro and in vivo. These results identify a new tumor suppressor gene-regulated, DNA damage-inducible arrest that occurs simultaneously with the G(1) and G(2) arrests but is genetically separable from them. We suggest that aberrant regulation of cell size during cell cycle arrest may be important in human cancer pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available